Pharmaceutical company developing HDL-related therapies for cardiovascular and metabolic diseases
Get notified the moment CERENIS THERAPEUTICS HOLDING S.A. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.